ϩ/Ϫ (109 Ϯ 2 to 134 Ϯ 3 mmHg, P Ͻ 0.001, n ϭ 8) and NCX1 smϪ/Ϫ (101 Ϯ 8 to 129 Ϯ 8 mmHg, P Ͻ 0.01, n ϭ 6) mice to a similar extent (⌬25 Ϯ 1 vs. ⌬28 Ϯ 4 mmHg, P Ͼ 0.05). In response to ANG II infusions, PAH clearance (CPAH) decreased from 1.39 Ϯ 0.27 to 0.98 Ϯ 0.22 ml·min Ϫ1 ·g Ϫ1 (P Ͻ 0.05) and glomerular filtration rate (GFR) was reduced from 0.50 Ϯ 0.09 to 0.32 Ϯ 0.06 ml·min Ϫ1 ·g Ϫ1 (P Ͻ 0.05) in NCX1 ϩ/Ϫ mice. In contrast, the NCX1 smϪ/Ϫ did not exhibit significant reductions in either CPAH (1.16 Ϯ 0.30 to 1.22 Ϯ 0.34 ml·min Ϫ1 ·g Ϫ1 , P Ͼ 0.05) or GFR (0.48 Ϯ 0.08 to 0.41 Ϯ 0.05 ml·min Ϫ1 ·g Ϫ1 , P Ͼ 0.05) during acute ANG II infusions. Using flometry to measure renal blood flow continuously, NCX1 smϪ/Ϫ mice had significantly attenuated responses to ANG II infusions (Ϫ34.2 Ϯ 3.9%, P Ͻ 0.05) compared with those in NCX1 ϩ/Ϫ mice (Ϫ48 Ϯ 2%) or in wild-type mice (Ϫ69 Ϯ 7%). These data indicate that renal vascular responses to ANG II are attenuated in NCX1 smϪ/Ϫ mice compared with NCX1 ϩ/Ϫ mice and that NCX1 contributes to the renal vasoconstriction response to acute ANG II infusions. sodium/calcium exchanger; renal vascular tone regulation; arterial pressure THE Na ϩ